ACTIVE SESSION TAPE Biotechnology $84M Cap Quant: HOLD

Why Is Connect Biopharma Holdings Limited (CNTB) Stock Down Today?

Updated Nov 17, 2026 2:48 PM ET · Prev Close $0.64

Pro Workspace
Last Session Price
$0.59 -7.94%
-$0.05 vs $0.64 prior close
Intraday Range
$0.55 – $0.64
Open $0.57
Relative Volume
1.28x Avg
819,716 sh
52-Week Range
$0.55 – $3.82
Benchmark Alpha
-6.60% vs SPY
-6.67% vs QQQ
20-Session Trend -25.8%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Connect Biopharma Holdings Limited Pulling Back 7.94% on 1.28x Relative Volume

Connect Biopharma Holdings Limited (CNTB) is pulling back 7.94% (-$0.05) to $0.59 on 1.28x average session volume. Relative to benchmarks, CNTB is lagging the S&P 500 by -6.60%. 14-day RSI stands at 25.6, keeping momentum in a oversold regime.

NEWS 70% Weight
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update

Reported positive preliminary topline data from global Phase 2 Seabreeze STAT studies evaluating rademikibart as an adjunct treatment for acute exacerbations of asthma and chronic obstructive pulmonary disease COPD Plans

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.59) trades relative to 20-day SMA ($0.75) and 50-day SMA ($0.99).

Volume Confirmation
MODERATE VOLUME (1.28x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

CNTB lagging the S&P 500 by -6.60%
CNTB Session
-7.94%
$0.59
S&P 500 (SPY)
-1.34%
$730.04
Nasdaq 100 (QQQ)
-1.27%
$653.34
Healthcare (XLV)
-1.36%
$185.33
Alpha vs SPY: -6.60% Alpha vs QQQ: -6.67% Alpha vs XLV: -6.58%

Options Flow & Execution Desk

Recent CNTB Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.56
Short-term support band
Upper Bound
$0.62
Short-term resistance band
Key Inflection Level
$0.55 (session support)

Monitor volume expansion above 1.5x RVOL around $0.55 (session support) for directional breakout confirmation.

Technical Regime (CNTB)

BEARISH MA TREND
RSI (14)
25.6
Oversold
20-Day SMA
$0.75
Below 20d
50-Day SMA
$0.99
Below 50d
MACD Signal
Bullish
MACD -0.11
ADX (14)
15.5
Weak trend
10d Momentum
-0.16
Soft 10-day momentum

Retail & Crowd Sentiment

Very Bullish
24h Messages
10
4.7x 7d avg
Bullish / Bearish
100.0% / 0.0%
Moderate buzz
Crowd Discussion Digest

Connect Biopharma reported positive preliminary topline data from Phase 2 Seabreeze STAT studies for rademikibart as an adjunct treatment for acute exacerbations of asthma and COPD. The company plans to engage with the FDA to discuss potential Phase 3 programs.

About Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways …

Sector
Healthcare
Market Cap
$84M
Forward P/E
0.8x
Employees
62

Get Instant CNTB Catalyst Alerts

Receive an email alert when CNTB triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

CNTB Session & Catalyst FAQ

Why is CNTB stock down today?

Connect Biopharma Holdings Limited (CNTB) is pulling back 7.94% (-$0.05) to $0.59 on 1.28x average session volume. Relative to benchmarks, CNTB is lagging the S&P 500 by -6.60%. 14-day RSI stands at 25.6, keeping momentum in a oversold regime.

Is CNTB stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.28x relative volume (moderate participation). Our multi-factor model currently rates CNTB as HOLD. Review full valuation, quality, and timing signals on the CNTB Buy or Sell Decision Brief →

What is CNTB's intrinsic value and expected trading range?

At $0.59, CNTB's modeled 1-to-3 session range is $0.56 – $0.62, with a key inflection level at $0.55 (session support). Compare current price against multi-year cash flow projections in the CNTB Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for CNTB?

RSI at 25.6 indicates oversold conditions — watch for mean-reversion support. CNTB trades at $0.59 relative to its 20-day SMA ($0.75) and 50-day SMA ($0.99), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs